Johnson & Johnson Failed to Disclose Injuries Caused by Insulin Pumps

Posted on Jan 19, 2012

In a report from the Associated Press, Johnson & Johnson failed to disclose serious injuries caused by insulin pumps, resulting in a U.S. Food and Drug Administration (FDA) warning. 

The FDA has issued warnings of potential fines and other repercussions if Animas Corp., a division of Johnson & Johnson, doesn’t correct violations stemming from faulty insulin pumps. This affects the One Touch Ping and 2020 pumps.

The FDA is asking for an explanation as to why they continued to sell the insulin pumps, despite evidence of serious injuries to consumers. They are also asking for a plan to be developed that will prevent any future incidences of failing to report serious injuries or death caused by one of their products.

Some of the complications stemming from the insulin pumps included:  

• respiratory failure;
• significantly elevated blood sugar levels;
• coma; and
• a life-threatening condition known as diabetic ketoacidosis. 

Johnson & Johnson is already in the spotlight following other recalls that have been issued due to dangerous products including:  

• hip implants;
• contact lenses;
• over-the-counter medications; and
• prescription drugs.  

When you or a loved one has suffered a serious or fatal injury caused by a defective product, you may have the right to compensation. You should immediately seek assistance from a New Jersey defective product attorney to understand what your rights are as a consumer.

Help from a New Jersey Defective Product Attorney

If you have been severely injured as a result of a defective product, you shouldn’t have to suffer and pay for expensive medical bills that were caused by another person’s negligence. Contact a New Jersey defective product attorney at White & Williams LLP today. We will provide a free, no obligation consultation on your case – 1-877-944-8396.

back to top